HIV
Juluca for HIV: What Pharmacists Should Know
Juluca for HIV: What Pharmacists Should Know
This article highlights several key therapeutics areas with the prescription medication.
Read More >>
Researchers and Clinicians Confront Today's HIV Profile
Syringe Sales Without a Prescription: What Pharmacists Think
Falling Sodium Levels in HIV: Watch the Velocity of the Change
Menopause and HIV: Data Gap, Limited Care
Ibalizumab-uiyk for HIV: What Pharmacists Should Know
HIV and Neurology: An Overview of Complications and Challenges
Lightening the Load: Looking for a Cure for HIV
View more articles >>
Clinical Trials
Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate
Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients
Reaching 90% HIV Suppression: The Role of POC Viral Load Monitoring in Nigeria
Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Messaging and Cell Phone Support Embedded Within the Sequential Multiple Assignment Randomized Trial (SMART) Design
B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults
Multimedia: Videos
WHO Report Identifies Priority Areas for HIV Pharmacy Research
WHO Report Identifies Priority Areas for HIV Pharmacy Research
WATCH: WHO Guide to Testing Options for HIV
WATCH: WHO Guide to Testing Options for HIV
Role of the Health-System Pharmacist in Treating Newly Admitted HIV Patients
Role of the Health-System Pharmacist in Treating Newly Admitted HIV Patients
Advancing the Treatment of HIV/AIDS Until There Is a Cure
Advancing the Treatment of HIV/AIDS Until There Is a Cure